# Coapt Systems, Inc.

- Location (FDA's records): Palo Alto, CA
- FDA decisions: 17 (2002–2009): 17 510(k) clearances
- Product codes: HWC (10), GAM (4), MIX (3)
- Predicates its devices cite: 29 (21 its own); citations of its devices by later devices: 27 (21 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Biomet, Inc.: 4 (https://510kreport.com/company/biomet)
- ETHICON, Inc.: 2 (https://510kreport.com/company/ethicon)
- Surgical Specialties Corp: 1 (https://510kreport.com/company/surgical-specialties)
- Bioform, Inc.: 1 (https://510kreport.com/company/bioform)

## Firms that cite its devices most
- Cytophil, Inc.: 4 (https://510kreport.com/company/cytophil)
- Surgical Specialties Corp: 2 (https://510kreport.com/company/surgical-specialties)

## Its most-cited devices
- K014153: Coapt Systmes Endotine Device (2002), cited by 8
- K023922: Coapt Systems Endotine Device, Model CFD-101-00197 (2002), cited by 6
- K080956: Modification to VF Gel Plus (2008), cited by 3
- K071663: VF Gel Plus (2008), cited by 3
- K040740: Endotine Transbleph Device (2004), cited by 2
- K032698: Coapt Endotine Midface-ST 4.5 Device (2003), cited by 2

## Recent decisions
- K083783: VF Liquigel (Sep 11, 2009)
- K080956: Modification to VF Gel Plus (Apr 25, 2008)
- K071663: VF Gel Plus (Feb 15, 2008)
- K060248: Ultratine Transbleph (Jun 12, 2006)
- K060249: Ultratine Forehead (Jun 12, 2006)
- K060828: Modification to Endotine Ribbon (Apr 19, 2006)
- K051415: Endotine Ribbon (Jun 23, 2005)
- K050611: Endotine Ribbon (Apr 6, 2005)

Source page: https://510kreport.com/company/coapt-systems